Akron Bio Appoints Christopher Murphy as Chief Executive Officer
BOCA RATON, Fla. & SARASOTA, Fla.–Akron Bio (“Akron”), a provider of critical inputs for cell and gene therapies, today announced the appointment of Christopher Murphy as Chief Executive Officer. Akron is a portfolio company of Arcline Investment Management. Mr. Murphy is a biotechnology industry veteran with more than 30 years of experience in advanced therapy […]
